Live Breaking News & Updates on உருட்டுதல் ஸ்டோந் ஒட்டும்|Page 11
Stay updated with breaking news from உருட்டுதல் ஸ்டோந் ஒட்டும். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amnesty fighting volunteers & donors start to rally! Encouraging news! A sponsor has offered a new $1,000 matching offer to double your donations this weekend. Please help us quickly meet this match. In the last 48 hours, our illegal immigration & Amnesty fighting activists have started to refocus and rally to us to Stop Amnesty 2021. If we can continue to increase our fundraising response this weekend, we have a stronger chance of reengaging our volunteers fighting to stop Amnesty legislation next week! At the time of this message, our March 21 fundraising deadline is only two weeks away and we have raised $11,800 of $20,000 thanks to those of you who care deeply about America s future. ....
OSLO (dpa-AFX) - KPS Capital Partners LP said that it agreed to buy the global aluminum rolling business from Norsk Hydro ASA (NHY, NHYDY.PK, NHYDY.PK) for 1.38 billion euros or about $1.67 billion.KPS ....
(1) - BLA submitted with FDA s breakthrough therapy designation - SHANGHAI, China and REDWOOD CITY, Calif., March 03, 2021 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd. ( Junshi Biosciences , HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. ( Coherus , Nasdaq: CHRS) announced today the initiation of the rolling submission of the Biologics License Application ( BLA ) for toripalimab to the U.S. Food and Drug Administration ( FDA ) for the treatment of recurrent or metastatic nasopharyngeal carcinoma ( NPC ). A rolling submission allows Junshi Biosciences to submit sections of the BLA to the FDA as they are completed. Toripalimab has been granted Breakthrough Therapy Designation by the FDA for the treatment of recurrent or metastatic nasopharyngeal carcinoma based on preliminary clinical evidence indicating that the drug may demonstrate substantial improvement over existing therapies. The designation is intended to expedite the development and review o ....
Rolling Stock Market worth $64.3 billion by 2025 - Exclusive Report by MarketsandMarkets Rolling Stock Market by Product Type (Locomotive, Rapid Transit, Wagon, and Coach), Locomotive Technology (Conventional, Turbocharged, and Maglev), Application (Passenger and Freight) & Region - Global Trends and Forecast to 2025 , published by MarketsandMarkets, the Rolling Stock Market is estimated to be USD 51.6 billion in 2020 and is projected to grow to USD 64.3 billion by 2025, at a CAGR of 4.5% during the forecast period. The growing demand for public transport and increasing need for energy efficient transport are some of the key drivers fueling the growth of this market. Increasing urbanization, adoption of public transport as a means of reducing traffic congestion, growing demand for energy-efficient transport and increasing adoption of rolling stocks for freight transportation are major drivers of the Rolling Stock Market. ....